Novocure Announces 38 Presentations on Tumor Treating Fields at 21st Annual Scientific Meeting of the Society of Neuro-Oncology It looks like Optune is finally getting the respect that it deserves. When it was first introduced, I would say most neuro-oncologists dismissed it without looking at data, based solely on preconceived notions that it couldn't possible work. Now, most seem to at least allow their patients to try it, if not encourage them to try it. The holdouts tell me that the data is preliminary and they will wait for the full report. Well - that will come out next week! I did not see it yet, but I assume from this press release that it is favorable. Hopefully that will remove the last doubt that this should be part of the standard of care for newly diagnosed Glioblastomas.
It is very significant that most of the presentations are from researchers not associated with the company. That shows broad acceptance in the field.
United Healthcare Issues Positive Coverage Decision for Optune This has been a big battle to get insurance to pay for Optune. United Healthcare was basically the last private insurance that didn't pay - now almost all do. Next up is the Medicare battle. I have been working on that one for a while and getting closer. I may need your help soon - we are thinking of another petition campaign!
New vaccine for brain cancer brings hope to those fighting the disease This is a new vaccine for GBM patients. Nice video - they say "Doctors say for many of the patients, there is no evidence of recurrence and those newly diagnosed with glioblastoma may be the best candidates for this treatment." Of course, there aren't enough patients treated yet to prove it works, but it is fantastic to have patients respond for long periods of time.
